Drug companies say enough US states have joined $ 26 billion opioid settlement to proceed

September 4 (Reuters) – Three major U.S. drug distributors and drugmaker Johnson & Johnson (JNJ.N) to move forward with a proposed $ 26 billion settlement resolving claims they fueled the outbreak of opioids after “enough” states joined the deal, according to Saturday letters reviewed by Reuters.

(This story has been corrected to remove reference to the Eight State Agreement)

Reporting by Nate Raymond in Boston Editing by Matthew Lewis and Sonya Hepinstall

Our Standards: Thomson Reuters Trust Principles.